The future of cystic fibrosis can be different thanks to personalized medicine


Researchers are growing mini gut and lung “avatars” derived from cells of children with cystic fibrosis.
Patients’ stem cells are collected at 11 CF clinics across Australia.
Stem cells are grown into miniature versions of the gut and lung.
Mini-organs are then frozen and preserved in the ECF biobank for future testing.
ECF AVATAR platform uses patient-derived mini-organs to assess the best medication for each patient.
Research is done by the University of New South Wales.

40% of patients with CF don't respond to treatment because of rare mutations

Mentioned in this article:

Resource Adam Jaffe - Professor and Paediatric Respiratory and Sleep Medicine Physician

Resource University of New South Wales (UNSW) - Public Research university.

Read full article on Cystic Fibrosis News Today website
More Personalised Medicine information, news and resources